After a $2.07M September sale, a 10% holder proposes selling more Arteris (AIP) shares.
Bayview Legacy, a 10% stockholder of Arteris, Inc. (AIP), has proposed to sell 300,000 shares of common stock with an aggregate market value of $7.09 million. This proposed sale follows previous transactions, including a $2.07 million sale of 100,000 shares on September 1, 2026. The shares were originally acquired through a private acquisition from the issuer in November 2013.
Form 144 | Arteris(AIP.US) 10% Stockholder Proposes to Sell 7.09 Million in Common Stocks
A 10% stockholder of Arteris (AIP.US) has filed a Form 144 proposing to sell 7.09 million common stocks. This regulatory filing indicates a significant potential stock sale by a major shareholder, which could be of interest to investors tracking insider activity and stock movements for Arteris.
Form 144 ARTERIS INC For: 1 October By Investing.com
This article from Investing.com announces the filing of Form 144 for ARTERIS INC on October 1st. Form 144 is typically filed with the SEC when an insider intends to sell restricted or controlled securities. The brief notice provides no further details beyond the company, form type, and date.
AIP Should I Buy
Arteris Inc (AIP) is currently rated as a "Good Buy" with a price of $23.89, showing a year-to-date change of +53.34% and a bullish RSI of 60.24. Analysts from Craig-Hallum and Jefferies have set price targets of $30 and $50, respectively, indicating significant potential upside despite a reported net loss of -14,065,000 USD in Q2 2026. The positive outlook is driven by analyst upgrades and confidence in future profitability from automotive and AI programs, while the negative net income remains a key risk.
Craig-Hallum Initiates Arteris(AIP.US) With Buy Rating, Announces Target Price $30
Craig-Hallum has initiated coverage on Arteris (AIP.US) with a Buy rating. The firm has set a target price of $30 for the company's stock.
Arteris Expands Multi-Die Chiplet-Based Portfolio
Arteris, Inc. has expanded its multi-die portfolio with the new FlexGen Multi-Die product, designed to help semiconductor companies transition from monolithic SoC designs to chiplet-based architectures for AI, HPC, and consumer electronics. This expansion, along with Ncore Multi-Die, Magillem integration automation, and Cycuity hardware security assurance, aims to provide comprehensive solutions for complex multi-die designs. The company emphasizes preserving architectural intelligence across multiple dies and improving design reuse while reducing integration complexity.
A Look at Arteris Inc (AIP) After 7.1% Gain -- GF Value $10.95 v
Arteris Inc (AIP) shares recently gained 7.1% but are considered significantly overvalued by GuruFocus, trading at $22.35 against a GF Value™ of $10.95. The company has a GF Score™ of 59/100, with strong growth but poor profitability and valuation. While some gurus are increasing their positions, significant insider selling raises concerns about the stock's future.
Arteris (AIP) executive lines up another stock sale
Arteris, Inc. (AIP) officer Laurent Moll has filed a Form 144 notice to sell 12,219 shares of common stock through Morgan Stanley Smith Barney, valued at $277,249.11 as of September 14, 2026. This planned sale includes shares from Restricted Stock Units and an Employee Stock Purchase Plan, following previous sales by Moll in June and July 2026. The filing indicates a neutral impact and sentiment according to Rhea-AI.
Arteris Expands Multi-Die Portfolio With FlexGen Multi-Die for AI, HPC and Chiplet-Based Architectures
Arteris, Inc. has expanded its multi-die portfolio with the new FlexGen Multi-Die product, designed to help semiconductor companies transition from monolithic system-on-chip designs to chiplet-based architectures. This innovation specifically targets AI, high-performance computing (HPC), and consumer electronics, addressing the challenges of data communication across chip boundaries. The FlexGen Multi-Die product extends network-on-chip (NoC) connectivity transparently across die-to-die links, aiming to simplify integration, maintain performance, and accelerate development for complex multi-die systems.
Arteris Grants Inducement Equity Awards to New CFO Saurabh Sinha | AIP Stock News
Arteris, Inc. has granted inducement equity awards to its new CFO, Saurabh Sinha, consisting of restricted stock units (RSUs) valued at $3.7 million and performance stock units (PSUs) valued at $1 million. These awards are part of the company's 2022 Employment Inducement Incentive Plan and are tied to Mr. Sinha's continued service and specific company performance targets for the PSUs, including revenue and stock price goals. The grants were effective September 8, 2026, and aim to incentivize strong leadership and align executive interests with shareholder value.
Arteris Inc (AIP) Stock Up 3.4% but GF Value Says Overvalued -- GF Score: 60/100
Arteris Inc (AIP) shares recently rose by 3.4%, but GuruFocus's GF Value suggests the stock is 96.2% overvalued with a fair value of $10.89 compared to its current trading price of $21.37. The company's GF Score is 60/100, indicating above-average performance driven by strong growth potential but hindered by poor profitability and high valuation. Despite some gurus increasing their stakes, significant insider selling raises concerns about the stock's immediate prospects.
Arteris VP & general counsel Paul Alpern sells $83,063 in shares
Paul L. Alpern, VP and General Counsel at Arteris Inc. (NASDAQ:AIP), sold 4,000 shares of common stock for approximately $83,063 on September 1, 2026, under a pre-arranged trading plan. Concurrently, he acquired 4,000 shares by exercising incentive stock options. Despite a recent stock decline, Arteris reported strong Q2 2026 revenue, leading Jefferies to upgrade its stock rating to Buy.
Bayview Legacy, Arteris 10% owner, sells $2.07m in stock By Investing.com
Bayview Legacy, LLC, a 10% owner and director of Arteris, Inc. (NASDAQ:AIP), sold 100,000 shares of the company's common stock for $2.07 million on September 1, 2026. This sale, executed under a pre-arranged trading plan, occurred amidst recent stock volatility, with shares declining 12% in the prior week. Despite the sale and current overvaluation according to InvestingPro, Arteris recently reported strong Q2 2026 revenues exceeding forecasts, leading Jefferies to upgrade its stock rating to Buy with a raised price target.
Arteris CEO K. Charles Janac sells 100,000 shares for $2.07 million By Investing.com
K. Charles Janac, CEO of Arteris, Inc. (AIP), sold 100,000 shares of company stock for $2.07 million on September 1, 2026, under a pre-arranged trading plan. This sale occurred after AIP's stock saw a significant 134% return over the past year, although it had declined 6% in the week prior to the transaction. The stock is currently trading above its Fair Value, suggesting limited upside according to InvestingPro analysis, despite the company recently exceeding Q2 2026 revenue expectations and receiving an upgrade to "Buy" from Jefferies.
Arteris Insider Bayview Legacy Disposes 100,000 Shares at $20.75 Each on September 1, 2026
Bayview Legacy, an insider at Arteris, sold 100,000 shares of Arteris stock at $20.75 per share on September 1, 2026. Following this transaction, Bayview Legacy's ownership in Arteris stands at 8,229,071 shares. This sale updates investors on the insider's holdings post-transaction.
Bayview Legacy, Arteris 10% owner, sells $2.07m in stock
Bayview Legacy, a 10% owner of Arteris Inc. (NASDAQ:AIP), sold 100,000 shares of the company's common stock for $2.07 million on September 1, 2026. This sale was conducted under a pre-arranged 10b5-1 trading plan and occurred amidst recent stock volatility. The company, Arteris, also reported strong Q2 2026 financial results, with revenue exceeding forecasts and an upgraded stock rating from Jefferies.
Arteris | 4: Statement of changes in beneficial ownership of securities-Officer Alpern Paul L
This document reports a statement of changes in beneficial ownership of securities for Arteris, specifically related to Officer Paul L. Alpern. It is identified as a Form 4 filing, indicating a transaction that alters his ownership stake in the company.
Bayview Legacy LLC Sells 100,000 Shares of Arteris Inc Stock Under Rule 10b5-1 Plan
Bayview Legacy LLC sold 100,000 shares of Arteris, Inc. common stock on September 1, 2026, under a Rule 10b5-1 trading plan. The shares were sold at a weighted average price of $20.7497 per share, with individual transaction prices ranging from $20.465 to $21.410. After this transaction, Bayview Legacy LLC, a 10% owner of Arteris, Inc., retains beneficial ownership of 8,229,071 shares.
Arteris, Inc. (AIP) Reports Q1 Loss, Beats Revenue Estimates
Arteris, Inc. (AIP) reported a Q1 loss of $0.03 per share, exceeding the Zacks Consensus Estimate of a $0.08 loss and surpassing year-ago results. The company also beat revenue estimates, posting $22.94 million against an estimated $21.1 million. Despite mixed estimate revisions, Arteris currently holds a Zacks Rank #3 (Hold).
Will Arteris, Inc. (AIP) Report Negative Earnings Next Week? What You Should Know
Arteris, Inc. (AIP) is expected to report a year-over-year increase in earnings on higher revenues for the quarter ended June 2026, with an estimated loss of $0.05 per share. However, the Zacks Earnings ESP is -20.00%, combined with a Zacks Rank of #3, making it difficult to definitively predict an earnings beat. Investors are advised to consider other factors in addition to the Earnings ESP and Zacks Rank.
Arteris (AIP) Is Down 6.0% After Raising 2026 Revenue Outlook And Naming New CFO
Arteris (AIP) shares dropped 6.0% after the company reported Q2 2026 results, showing increased revenue but also widened net losses. The company raised its full-year 2026 revenue outlook to US$95.0 million–US$98.0 million and appointed Saurabh Sinha as its new CFO. This update highlights the ongoing trade-off for investors between the company's accelerating top-line growth driven by AI and chiplet demand, and its persistent operating losses.
Arteris (AIP) Is Down 6.0% After Raising 2026 Revenue Outlook And Naming New CFO
Arteris (AIP) reported mixed Q2 2026 results, with revenue rising to US$24.13 million but net loss widening to US$14.07 million. Despite raising its 2026 revenue outlook to US$95.0 million–US$98.0 million and appointing Saurabh Sinha as its new CFO, the company's stock fell 6.0%. The article highlights the ongoing tension between accelerating revenue growth, driven by AI and chiplet design activity, and increasing operating losses.
Nicholas Hawkins Sells 10,431 Shares of Arteris (NASDAQ:AIP) Stock
Arteris CFO Nicholas Hawkins sold 10,431 shares of Arteris (NASDAQ:AIP) stock for approximately $294,780, reducing his ownership by 9.83%. Despite this insider sale and a recent earnings miss, the stock rose 2.6%, and analysts maintain a "Moderate Buy" rating with an average price target of $41.00. Institutional investors hold a significant 64.36% of the company's stock.
Arteris CFO Nicholas B. Hawkins Executes Stock Option and Sells Shares in August 2026
Arteris, Inc.'s CFO, Nicholas B. Hawkins, executed multiple stock transactions in August 2026, including exercising a non-qualified stock option for 3,125 shares and selling a total of 10,631 shares. These transactions resulted in his direct beneficial ownership decreasing to 95,666 shares, while he still retains 31,250 non-qualified stock options with a $9.28 exercise price. The detailed activities were disclosed in a Form 4 filing.
Arteris | 4: Statement of changes in beneficial ownership of securities-Officer Hawkins Nicholas B.
This document is a statement of changes in beneficial ownership of securities for Officer Nicholas B. Hawkins of Arteris, filed under Form 4. It details transactions involving the company's securities by an insider.
AIP (AIP) insider Nicholas Hawkins outlines planned sale of 10,431 shares
Nicholas Hawkins, an insider at Arteris, Inc. (AIP), has filed to sell 10,431 shares of common stock, valued at approximately $294,828.04, through Morgan Stanley Smith Barney LLC. This proposed sale includes shares from restricted stock vesting on July 6, 2026, and an option exercise on August 13, 2026. The filing also reports significant past sales by Hawkins, including over 221,000 shares in May 2026.
Arteris | 144: Notice of proposed sale of securities pursuant to Rule 144
This article is a notice of a proposed sale of securities by Arteris, filed pursuant to Rule 144. It indicates that the company is intending to sell securities as per regulatory requirements.
Insider (AIP) files Form 144 notice for 200-share stock sale
Nicholas B. Hawkins, an insider at Arteris, Inc. (AIP), has filed a Form 144 notice to sell 200 shares of common stock through Morgan Stanley Smith Barney LLC on August 12, 2026, with an aggregate market value of $5,800. These shares stem from restricted stock vesting under a registered plan, acquired as compensation. Hawkins has also reported previous sales totaling over 224,000 shares in the past three months.
Arteris, Inc. 2026: Revenue $24.13M, EPS ($0.3) — 10-Q Summary
Arteris, Inc. (AIP) reported its 2026 quarterly results, showing a significant increase in revenue to $24.13 million, up 46.2% from the prior year. Despite revenue growth, the company recorded a net loss of ($14.07 million) and a diluted loss per share of ($0.30). The company attributed revenue growth to higher product demand, improved pricing, and a shift towards direct-to-consumer sales, with management expecting continued top-line expansion and margin improvement.
Arteris (NASDAQ:AIP) Shares Down 7.2% - Time to Sell?
Arteris (NASDAQ:AIP) shares dropped 7.2% to $27.63 on Monday, trading below its 50-day moving average, though above its 200-day average. The company recently missed quarterly EPS expectations, reporting a $0.10 loss per share against a projected $0.04 loss, despite slightly exceeding revenue forecasts. Despite a "Moderate Buy" consensus rating from analysts, significant insider selling, totaling nearly $52.2 million in shares over the past 90 days, raises questions about the stock's immediate future.
Arteris, Inc. (NASDAQ:AIP) Given Consensus Rating of "Moderate Buy" by Brokerages
Arteris, Inc. (NASDAQ:AIP) has received a "Moderate Buy" consensus rating from brokerages, with an average 12-month price target of $41.00. While the company exceeded revenue expectations in the second quarter and provided strong third-quarter and full-year guidance, it also reported a larger-than-expected loss per share. Insider selling has been noted, but institutional ownership remains strong, with a significant new position from BlackRock.
Jefferies upgrades Arteris stock rating on profitability outlook
Jefferies has upgraded Arteris, Inc. (NASDAQ:AIP) stock from Hold to Buy and raised its price target to $50.00, citing increased confidence in the company's path to non-GAAP profitability by Q4 2026. The firm notes that Arteris's growth story is expanding beyond AI to include security through the Cycuity acquisition, and it expects royalties to accelerate into 2028. This upgrade follows a strong performance with record bookings and a 46% revenue increase year-over-year, despite a wider-than-anticipated Q2 2026 loss per share.
Did Arteris' (AIP) Raised 2026 Outlook and AI Wins Just Recast Its Investment Narrative?
Arteris, Inc. reported Q2 2026 results with increased revenue and wider net losses, while also raising its full-year 2026 revenue outlook to US$95.0–US$98.0 million. The company highlighted record contract values, significant AI and data center design wins, and a new capital raise, reinforcing the relevance of its network-on-chip technology in complex semiconductor designs. Despite these positive developments and an upgraded outlook, the company continues to face challenges with profitability and potential dilution risks.
Did Arteris' (AIP) Raised 2026 Outlook and AI Wins Just Recast Its Investment Narrative?
Arteris, Inc. (AIP) recently reported its second-quarter 2026 results, showing increased revenue and a wider net loss, but also raised its full-year 2026 revenue outlook. The company highlighted record contract values, significant AI and data center design wins, and new capital raised, which strengthens its near-term revenue prospects. However, investors are cautioned about the ongoing losses, potential share dilution, and execution risks despite the growth path.
Arteris, Inc. Stock 12‑Month Price Target Raised to $41, Implies 30% Upside
The average 12-month price target for Arteris, Inc. (AIP) stock has been raised from $39.33 to $41 by 6 analysts, with forecasts ranging from $38 to $50 per share. This new target suggests a potential upside of approximately 30% from the Aug. 6 closing price. All 6 covering analysts maintain a "Buy" rating for the stock.
Sei Investments Co. Raises Position in Arteris, Inc. $AIP
Sei Investments Co. increased its stake in Arteris, Inc. (NASDAQ:AIP) by 43.1% in the first quarter, acquiring an additional 51,279 shares to own a total of 170,272 shares valued at $2.8 million. Despite institutional investor confidence and a "Moderate Buy" consensus rating from analysts with an average target price of $41, insider selling remains a concern, with nearly 1.5 million shares sold by company insiders totaling $52.2 million over the past 90 days. The company's Q2 earnings showed a revenue beat but a wider-than-expected adjusted loss per share, though Q3 and full-year 2026 revenue guidance exceeded consensus estimates.
Arteris (AIP) Stock Revenue Growth Collides With Widening Losses
Arteris (AIP) reported strong Q2 2026 revenue of US$24.1 million, driven by record annual contract value and royalties, indicating solid demand for its chip networking IP, particularly from AI and data center sectors. However, investor sentiment was negative due to widening losses, with net loss increasing to US$14.07 million and basic EPS loss deepening to US$0.30 per share, raising concerns about the company's path to profitability despite its growth.
Jefferies upgrades Arteris stock rating on profitability outlook
Jefferies has upgraded Arteris Inc. (NASDAQ:AIP) stock rating from Hold to Buy and increased its price target to $50.00, citing increased comfort with the company's path to non-GAAP profitability. The firm expects Arteris to achieve profitability by Q4 2026, driven by an 88% gross profit margin, expanding AI-related licensing growth, and contributions from the Cycuity acquisition. Despite a recent Q2 2026 loss, Arteris reported strong revenue, record bookings, and raised its full-year guidance, with Jefferies projecting significant earnings potential by 2030.
Arteris Inc (AIP) (Q2 2026) Earnings Call Highlights: Record ACV and Revenue Surge 46%
Arteris Inc. (AIP) reported a strong Q2 2026, with revenue surging 46% year-over-year to $24.1 million and annual contract value (ACV) plus royalties reaching a record $99.5 million. Despite a non-GAAP operating loss of $4.6 million, impacted by payroll taxes and commissions, the company raised its full-year 2026 revenue guidance to $95-$98 million and expects to achieve non-GAAP operating profitability by Q4 2026. Key growth drivers included major design wins with a hyperscale cloud company and a top US semiconductor firm, as well as the successful completion of an ATM program raising $72 million.
Arteris | 10-Q: Quarterly report
This article is a quarterly report (Form 10-Q) filed by Arteris. It provides a formal regulatory update on the company's financial performance and operations for the specified quarter.
Arteris, Inc. (AIP) Stock Price, News, Quote & History
This article provides comprehensive financial data for Arteris, Inc. (AIP), including its stock price, historical performance, key statistics, and analyst ratings. It also offers an overview of the company's semiconductor IP solutions and its market presence. The stock closed at $31.62, up 2.23%, but was down 6.10% in pre-market trading.
Arteris, Inc. (AIP) Reports Q2 Loss, Tops Revenue Estimates
Arteris, Inc. (AIP) reported a Q2 loss of $0.1 per share, which missed the Zacks Consensus Estimate of a $0.05 loss. However, the company's revenues for the quarter reached $24.13 million, surpassing the consensus estimate by 2.86%. Despite the earnings miss, Arteris shares have performed strongly year-to-date, gaining 99.6% compared to the S&P 500's 12.8% increase.
Arteris Q2 Earnings Call Highlights
Arteris reported record second-quarter results for 2026, with significant growth in revenue, annual contract value plus royalties, and remaining performance obligations, driven by strong demand across multiple sectors including enterprise computing and automotive. The company highlighted key wins in AI infrastructure and an expanded partnership with Arm for cybersecurity assurance, while also raising its full-year revenue outlook. Saurabh Sinha will become the new CFO on September 8th.
Arteris Q2 2026 slides: record revenue, royalties mask profitability gap
Arteris Inc. reported record revenue of $24.1 million and annual contract value plus royalties of $99.5 million for Q2 2026, both exceeding guidance. Despite strong top-line growth driven by demand in AI, data center, and automotive markets, the company posted a wider-than-expected non-GAAP operating loss of $4.6 million, causing its shares to fall. Arteris raised its full-year 2026 revenue outlook but also widened its operating loss forecast, highlighting the ongoing challenge of achieving profitability amidst significant expansion.
Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance
Arteris (Nasdaq: AIP) announced record-breaking financial results for Q2 2026, including 46% year-over-year revenue growth to $24.1 million and 44% growth in Annual Contract Value plus royalties to $99.5 million. The company reported strong customer engagement in various markets, with a 21% increase in design starts, largely driven by AI compute integration. Arteris also provided Q3 and updated full-year 2026 guidance, expecting continued growth and announced Saurabh Sinha will join as CFO.
Arteris earnings up next: Can chip IP play sustain AI momentum?
Arteris Inc. is set to report second-quarter results, with analysts expecting a loss of 4 cents per share on revenue of $23.5 million, reflecting significant year-over-year growth. Investors will focus on the acceleration of royalty revenue from automotive and AI design wins, and the company's path to sustained profitability, despite high gross margins. Management's commentary on design win momentum, especially from AI-enabled systems and the UCIe chiplet interconnect standard, will also be crucial.
Arteris Appoints Saurabh Sinha as Chief Financial Officer
Arteris, Inc. (Nasdaq: AIP) has announced the appointment of Saurabh Sinha as its new Chief Financial Officer, effective September 8, 2026. Sinha succeeds Nick Hawkins, who is retiring after seven years with the company and will assist with the transition. The company's President and CEO, K. Charles Janac, highlighted Sinha's extensive financial leadership experience in technology companies and expressed confidence in his ability to help Arteris scale and execute its long-term strategy in the AI and semiconductor innovation market.
Arteris CFO Nick Hawkins Retires After Seven Years With Company
Arteris (Nasdaq: AIP) announced the appointment of Saurabh Sinha as Chief Financial Officer, effective September 8, 2026. He will succeed Nick Hawkins, who is retiring after seven years but will remain as an advisor for a smooth transition. Sinha brings over 25 years of financial leadership experience from technology companies, including his recent role as CFO of Aeva Technologies.
Bayview Legacy sells 100,000 Arteris, Inc. (AIP) shares via plan
Bayview Legacy, LLC, a 10% owner of Arteris, Inc. (AIP), reported selling 100,000 shares of common stock through five indirect open-market transactions on August 3-4, 2026. These sales were executed under a Rule 10b5-1 trading plan adopted on December 12, 2025, with shares sold at weighted-average prices ranging from $28.17 to $32.48. K. Charles Janac, Bayview's manager, is deemed to have voting and dispositive power over these shares and also reported the transactions separately.
Arteris | 4: Statement of changes in beneficial ownership of securities-10% Owner Bayview Legacy, LLC
This document, titled "Arteris | 4: Statement of changes in beneficial ownership of securities-10% Owner Bayview Legacy, LLC," is a Form 4 filing. It indicates a statement of changes in beneficial ownership of securities for Arteris, specifically concerning Bayview Legacy, LLC, which is a 10% owner. The filing is a standard regulatory disclosure detailing changes in security holdings.
